IL137782A0 - Process for the obtaining of hmg-coa reductase inhibitors of high purity - Google Patents

Process for the obtaining of hmg-coa reductase inhibitors of high purity

Info

Publication number
IL137782A0
IL137782A0 IL13778299A IL13778299A IL137782A0 IL 137782 A0 IL137782 A0 IL 137782A0 IL 13778299 A IL13778299 A IL 13778299A IL 13778299 A IL13778299 A IL 13778299A IL 137782 A0 IL137782 A0 IL 137782A0
Authority
IL
Israel
Prior art keywords
hmg
coa reductase
reductase inhibitor
crystallization
water
Prior art date
Application number
IL13778299A
Other languages
English (en)
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL137782(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of IL137782A0 publication Critical patent/IL137782A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
IL13778299A 1998-02-18 1999-02-17 Process for the obtaining of hmg-coa reductase inhibitors of high purity IL137782A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9800046A SI9800046A (sl) 1998-02-18 1998-02-18 Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
PCT/IB1999/000808 WO1999042601A1 (fr) 1998-02-18 1999-02-17 PROCEDE D'OBTENTION D'INHIBITEURS TRES PURS DE LA HMG-CoA REDUCTASE

Publications (1)

Publication Number Publication Date
IL137782A0 true IL137782A0 (en) 2001-10-31

Family

ID=20432203

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13778299A IL137782A0 (en) 1998-02-18 1999-02-17 Process for the obtaining of hmg-coa reductase inhibitors of high purity

Country Status (21)

Country Link
US (1) US6825015B1 (fr)
EP (1) EP1054993B1 (fr)
JP (2) JP2002504345A (fr)
KR (1) KR100582620B1 (fr)
CN (1) CN1206363C (fr)
AT (1) ATE296357T1 (fr)
AU (1) AU743619B2 (fr)
BG (1) BG64289B1 (fr)
CA (1) CA2321052A1 (fr)
CZ (1) CZ297093B6 (fr)
DE (1) DE69925459T2 (fr)
HR (1) HRP20000541A2 (fr)
HU (1) HUP0100820A3 (fr)
IL (1) IL137782A0 (fr)
PL (1) PL193510B1 (fr)
RO (1) RO120922B1 (fr)
RU (1) RU2235130C2 (fr)
SI (2) SI9800046A (fr)
SK (1) SK285074B6 (fr)
WO (1) WO1999042601A1 (fr)
YU (1) YU50100A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02005283A (es) * 1999-11-30 2003-10-06 Biogal Gyogyszergyar Proceso para recuperar compuestos estatina de un caldo de fermentacion.
KR20020062340A (ko) 1999-12-14 2002-07-25 비오갈 기오기스제르갸르 알티. 신규 형태의 프라바스타틴 나트륨
WO2001062949A1 (fr) * 2000-02-24 2001-08-30 Biogal Gyogyszergyar Rt Procede de purification de jus de fermentation
TR200403001T3 (tr) 2000-03-03 2005-02-21 Plus Chemical, S.A. Lovastatin ve simvastatinin, azaltılmış dimerik katışkı seviyelerine sahip olacak şekilde arıtılması için bir işlem
IN192861B (fr) * 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
US6936731B2 (en) * 2000-10-05 2005-08-30 TEVA Gyógyszergyár Részvénytársaság Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
US6716615B2 (en) 2002-02-27 2004-04-06 Yung Shin Pharmaceutical Ind. Co., Ltd. Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
WO2005051372A2 (fr) 2003-11-24 2005-06-09 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Procédé de purification de pravastatine
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
ES2239533B1 (es) * 2004-03-01 2006-12-16 Ercros Industrial, S.A. Procedimiento para la obtencion de compactina.
CN102384955B (zh) * 2010-09-01 2014-04-30 北京北大维信生物科技有限公司 人体血浆中HMG－CoA还原酶抑制剂的定量分析方法
RU2585234C2 (ru) * 2013-12-27 2016-05-27 Открытое акционерное общество "Красфарма" Способ получения компактина
RU2585233C2 (ru) * 2013-12-27 2016-05-27 Открытое акционерное общество "Красфарма" Промышленный способ получения компактина

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
US4294846A (en) * 1979-09-21 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and products of preparation
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US4965200A (en) * 1989-06-23 1990-10-23 Merck & Co., Inc. Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs
US5202029A (en) 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
ATE189804T1 (de) * 1995-08-03 2000-03-15 Dsm Nv Selektives verfahren zur deacylierung von acylverbindungen
CA2243592C (fr) * 1995-12-06 2001-12-25 Antibiotic Co. Procede de production de lovastatine
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására

Also Published As

Publication number Publication date
WO1999042601A1 (fr) 1999-08-26
HRP20000541A2 (en) 2001-12-31
KR100582620B1 (ko) 2006-05-23
SI1054993T1 (en) 2005-10-31
PL193510B1 (pl) 2007-02-28
CA2321052A1 (fr) 1999-08-26
JP2005110693A (ja) 2005-04-28
CN1291238A (zh) 2001-04-11
BG64289B1 (bg) 2004-08-31
SK285074B6 (sk) 2006-05-04
SI9800046A (sl) 1999-08-31
RO120922B1 (ro) 2006-09-29
ATE296357T1 (de) 2005-06-15
YU50100A (sh) 2003-07-07
PL342513A1 (en) 2001-06-18
SK11852000A3 (sk) 2001-05-10
CZ20002856A3 (cs) 2000-11-15
HUP0100820A3 (en) 2003-07-28
AU3438499A (en) 1999-09-06
DE69925459T2 (de) 2006-04-27
BG104696A (en) 2001-07-31
RU2235130C2 (ru) 2004-08-27
EP1054993B1 (fr) 2005-05-25
KR20010041024A (ko) 2001-05-15
JP2002504345A (ja) 2002-02-12
DE69925459D1 (de) 2005-06-30
US6825015B1 (en) 2004-11-30
EP1054993A1 (fr) 2000-11-29
CZ297093B6 (cs) 2006-09-13
HUP0100820A2 (hu) 2001-08-28
AU743619B2 (en) 2002-01-31
CN1206363C (zh) 2005-06-15

Similar Documents

Publication Publication Date Title
HRP20000541A2 (en) PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
YU63602A (sh) Postupak za prečišćavanje fermentacionog bujona
CA2393057A1 (fr) Procede permettant de recuperer la pravastatine d'un bouillon de fermentation
MY116928A (en) Purification of crude acrylic acid by crystallization
RU2000124064A (ru) Способ получения ингибиторов hmg-coa-редуктазы высокой степени чистоты
WO2001068893A3 (fr) Hydrolyse et acidulation de soapstock par des bacteries acidogenes
AU2003290147A1 (en) High purity phthalein derivatives and method for preparing same
WO2001021607A3 (fr) Elaboration d'acide mycophenolique et de derives de cet acide
EP0927755A3 (fr) Haloacetoacetate-reductase,procédé de préparation et procédé de préparation d'alcohols avec cette enzyme
AU7432198A (en) Improved process for the fermentative production of penicillin
CA2202016A1 (fr) Procede de production de lipstatine et de tetrahydrolipstatine
ES2190441T3 (es) Procedimiento para la sintesis de inhibidores de hmg-coa reductasa.
ID26888A (id) Proses produksi fermentasi cephalosporin
AU547968B2 (en) Ml-236b derivatives i.e. alactone and the corresponding free hydroxy-carboxylic acid
ES2001410A6 (es) Un procedimiento para la preparacion de nuevos derivados de clavam, utiles para la preparacion de acido clavulanico, e intermedios de los mismos.
US5258290A (en) Fermentation process for the production of β-carboline derivatives by Myrothecium verrucaria
AU7759298A (en) Improved process for the fermentative production of cephalosporin
DE69718360D1 (de) Aldehyd Dehydrogenase
NO20045513L (no) Fremgangmate for fremstiling av konjugert linolsyre
WO2000052012A3 (fr) Procede de synthese de composes a base de porphyrine
WO2009078033A4 (fr) Isolement et récupération de simvastatine sous forme lactonique ou sous forme d'un sel acide à partir d'un bouillon de fermentation récolté
ES2297913T3 (es) Transformacion microbiana usando microorganismos del genero monosporium o thamostylum.
WO2002022849A3 (fr) Resolution enzymatique d'acides a substitution aryle et thio
EP0795607A3 (fr) Procédé de préparation d'une lactone
JP3917723B2 (ja) ラクトン加水分解酵素およびその製造法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees